Koshinski Asset Management, Inc. Bio N Tech Se Transaction History

Koshinski Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$123.25 - $186.24 $18,487 - $27,936	-150 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$126.25 - $231.85 $8.23 Million - $15.1 Million	-65,223 Reduced 99.77%	150 $25.6 Million
Q4 2020 Feb 02, 2021	BUY	$72.71 - $129.54 $4.75 Million - $8.47 Million	65,373 New	65,373 $2.01 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.